We have found that several dye compounds have the ability to inhibit the binding of HIV rgpl 20 to the Leu3a epitope of CD4 on PBL. One of these compounds, selected for further testing as the best candidate, can inhibit the growth of HIV In vitro. The tested dyes have varying degrees of specificity and efficacy in inhibiting the binding of rgpl 20. These results may point towards compounds that can be useful therapeutics against HIV.
References
1.
AnandR.NayyarS.GalvinT.A.MerrllC.R.BigelowL.B. (1990) Sodium pentosan polysulfate (PPS), an anti-HIV agent also exhibits synergism with AZT, lymphoproliferative activity and virus enhancement. AIDS Res Human Retrovir6: 679–689.
2.
AnandR.MooreJ.CurranJ.W.SrinivasanA. (1988) Interaction between rifabutin and human immunodeficiency virus type-1: inhibition of replication, cytopathic effect and reverse transcriptase in vitro. Antimicrob Agents Chemother32: 684–688.
3.
BalzariniJ.MitsuyaH.De ClercqE.BroderS. (1986a) Aurintricarboxylic acid and Evans Blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus. Biochem Biophys Res Commun136: 64–71.
4.
BalzariniJ.MitsuyaH.De ClercqE.BroderS. (1986b) Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV). Int J Cancer37: 451–457.
5.
CushmanM.WangP.ChangS.H.WildC.De ClercqE.ScholsD.GoldmanM.E.BowenJ.A. (1991a) Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: Distinct correlation of antiviral potency with molecular weight. J Med Chem34: 329–337.
6.
CushmanM.KanamathareddyS.De ClercqE.ScholsD.GoldmanE.BowenJ. (1991b) Synthesis and anti-HIV activities of low molecular weight aurintricarboxylic acid fragments and related compounds. J Med Chem34: 337–342.
7.
ItoM.BabaM.SatoA.PauwelsR.De ClercqE.ShigetaS. (1987) Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro. Antivir Res7: 361–367.
8.
KozlowskiM.R.WatsonA. (1990) Characterization of gp120 binding to the CD4 antigen and detection of specific inhibitors, Antivir Chem Chemother1: 175–182.
9.
LifsonJ.D.HwangK.M.NaraP.L.FraserB.PadgettM.DunlopN.M.EidenL.E. (1988) Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity. Science241: 712–716.
10.
SittigM. (1981) Handbook of Toxic and Hazardous Chemicals. Noyes Publications, New Jersey, pp. 78–80.
11.
SmithD.H.ByrnR.A.MarstersS.A.GregoryT.A.GroopmanJ.E.CaponD.J. (1987) Blocking of HIV-1 infectivity by a soluble, secreted form of CD4 antigen. Science238: 1704–1707.
12.
WangJ.YanY.GarretT.P.J.LiuJ.RodgersD.W.GarlickR.L.TarrG.E.HusainY.ReinherzE.L.HarrisonS.C. (1990) Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature348: 411–418.
13.
WeaverJ.L.GergelyP.PineP.S.PatzerP.S.AszalosA. (1990) Polyionic compounds selectively alter availability of CD4 receptors for HIV coat protein rgp120. AIDS Res Human Retrovir6: 1125–1130.
